AKEBIA THERAPEUTICS, INC. Accrued Vacation, Current
AKEBIA THERAPEUTICS, INC. (AKBA) had Accrued Vacation, Current of $926.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Employee-related Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2019-11-12
- 2019-09-30: Accrued Vacation, Current $926.00K.
- 2019-06-30: Accrued Vacation, Current $1.02M.
- 2019-03-31: Accrued Vacation, Current $1.06M.
- 2018-12-31: Accrued Vacation, Current $1.09M.
| Period end | Accrued Vacation, Current | Accrued Vacation, Current as first filed |
|---|---|---|
| 2019-09-30 | $926.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.02M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.06M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.09M 10-Q · filed 2019-11-12 | |
| 2018-09-30 | $858.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $940.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $873.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $797.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $691.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $681.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $625.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $513.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $378.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $433.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $425.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $310.00K 10-K · filed 2017-03-06 | |
| 2015-09-30 | $258.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $263.00K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $248.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $177.00K 10-K · filed 2016-03-14 | $177.16K 10-K · filed 2015-03-04 |
| 2014-09-30 | $179.22K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $153.15K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $120.60K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $109.92K 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |